Kjetil Garborg

3.4k total citations
24 papers, 835 citations indexed

About

Kjetil Garborg is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Kjetil Garborg has authored 24 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Kjetil Garborg's work include Colorectal Cancer Screening and Detection (14 papers), Gastric Cancer Management and Outcomes (11 papers) and Clostridium difficile and Clostridium perfringens research (6 papers). Kjetil Garborg is often cited by papers focused on Colorectal Cancer Screening and Detection (14 papers), Gastric Cancer Management and Outcomes (11 papers) and Clostridium difficile and Clostridium perfringens research (6 papers). Kjetil Garborg collaborates with scholars based in Norway, United States and Sweden. Kjetil Garborg's co-authors include Michael Bretthauer, Hans‐Olov Adami, Mette Kalager, Magnus Løberg, Øyvind Holme, Geir Hoff, Asbjörn Stallemo, Jon Matre, Anders Sundøy and Michał F. Kamiński and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Kjetil Garborg

23 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kjetil Garborg Norway 12 533 365 224 177 174 24 835
Alberto Fantin Italy 11 442 0.8× 311 0.9× 218 1.0× 159 0.9× 120 0.7× 40 740
Y F A Chung Singapore 15 311 0.6× 166 0.5× 407 1.8× 66 0.4× 107 0.6× 21 692
Wen‐Feng Hsu Taiwan 15 492 0.9× 315 0.9× 230 1.0× 17 0.1× 119 0.7× 37 698
Paolo Bocus Italy 16 200 0.4× 286 0.8× 391 1.7× 27 0.2× 52 0.3× 39 702
Nansheng Cheng China 15 191 0.4× 251 0.7× 333 1.5× 92 0.5× 37 0.2× 38 630
Ganesh R. Veerappan United States 15 306 0.6× 359 1.0× 834 3.7× 29 0.2× 92 0.5× 41 1.4k
Yecheskel Schneider United States 14 147 0.3× 169 0.5× 332 1.5× 81 0.5× 37 0.2× 62 668
Choong Kee Park South Korea 17 324 0.6× 362 1.0× 409 1.8× 27 0.2× 35 0.2× 76 990
Sho Saeki Japan 15 435 0.8× 427 1.2× 111 0.5× 76 0.4× 25 0.1× 94 913
Sang Young Han South Korea 13 99 0.2× 219 0.6× 222 1.0× 32 0.2× 110 0.6× 64 604

Countries citing papers authored by Kjetil Garborg

Since Specialization
Citations

This map shows the geographic impact of Kjetil Garborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kjetil Garborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kjetil Garborg more than expected).

Fields of papers citing papers by Kjetil Garborg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kjetil Garborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kjetil Garborg. The network helps show where Kjetil Garborg may publish in the future.

Co-authorship network of co-authors of Kjetil Garborg

This figure shows the co-authorship network connecting the top 25 collaborators of Kjetil Garborg. A scholar is included among the top collaborators of Kjetil Garborg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kjetil Garborg. Kjetil Garborg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Juul, Frederik Emil, Amanda J. Cross, Robert E. Schoen, et al.. (2024). Effectiveness of Colonoscopy Screening vs Sigmoidoscopy Screening in Colorectal Cancer. JAMA Network Open. 7(2). e240007–e240007. 14 indexed citations
2.
Garborg, Kjetil, et al.. (2024). 669 MITRIC: microbiota transplant to cancer patients progressing on immunotherapy using feces from clinical responders. Regular and Young Investigator Award Abstracts. A767–A767. 6 indexed citations
3.
Garborg, Kjetil, et al.. (2023). Forebygger probiotika nekrotiserende enterokolitt hos ekstremt premature?. Tidsskrift for Den norske legeforening. 143(4).
4.
Juul, Frederik Emil, Amanda J. Cross, Robert E. Schoen, et al.. (2022). 15-Year Benefits of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality. Annals of Internal Medicine. 175(11). 1525–1533. 27 indexed citations
5.
Juul, Frederik Emil, Kjetil Garborg, Magnus Løberg, et al.. (2022). Rates of repeated colonoscopies to clean the colon from low-risk and high-risk adenomas: results from the EPoS trials. Gut. 72(5). 951–957. 4 indexed citations
6.
Hoff, Geir, Edoardo Botteri, Ole Høie, et al.. (2019). Polyp detection rates as quality indicator in clinical versus screening colonoscopy. SHILAP Revista de lepidopterología. 7(2). E195–E202. 5 indexed citations
7.
Juul, Frederik Emil, Hilde Skudal, Håvard Wiig, et al.. (2018). 28 - Fecal Microbiota Transplant Versus Antibiotics for Primary Clostridium Difficile Infection – a Multicenter, Randomized Proof-of-Concept Trial. Gastroenterology. 154(6). S–10. 1 indexed citations
8.
Garborg, Kjetil, Thomas de Lange, & Michael Bretthauer. (2017). Quality Indicators in Colonoscopy. Current Treatment Options in Gastroenterology. 15(3). 416–428. 11 indexed citations
9.
Garborg, Kjetil, Håvard Wiig, Jon Matre, et al.. (2016). Gradual stiffness versus magnetic imaging‐guided variable stiffness colonoscopes: A randomized noninferiority trial. United European Gastroenterology Journal. 5(1). 128–133. 3 indexed citations
10.
Løberg, Magnus, et al.. (2016). Incentiver og deltagelse i en medisinsk spørreundersøkelse. Tidsskrift for Den norske legeforening. 136(12/13). 1082–1087. 4 indexed citations
11.
Eskeland, Sigrun Losada, Cathrine Brunborg, Birgitte Seip, et al.. (2016). First quality score for referral letters in gastroenterology—a validation study. BMJ Open. 6(10). e012835–e012835. 8 indexed citations
12.
Furuya‐Kanamori, Luis, Suhail A.R. Doi, David L. Paterson, et al.. (2016). Upper Versus Lower Gastrointestinal Delivery for Transplantation of Fecal Microbiota in Recurrent or Refractory Clostridium difficile Infection. Journal of Clinical Gastroenterology. 51(2). 145–150. 46 indexed citations
13.
Garborg, Kjetil. (2015). Colorectal Cancer Screening. Surgical Clinics of North America. 95(5). 979–989. 22 indexed citations
14.
Garborg, Kjetil. (2015). Anaerobically cultivated human intestinal microbiota as first-line treatment forClostridium difficileinfection. Microbial Ecology in Health and Disease. 26(0). 27710–27710. 1 indexed citations
15.
Garborg, Kjetil, Øyvind Holme, Magnus Løberg, et al.. (2013). Current status of screening for colorectal cancer. Annals of Oncology. 24(8). 1963–1972. 117 indexed citations
16.
Hoff, Geir, Michael Bretthauer, Kjetil Garborg, & T. J. Eide. (2013). New polyps, old tricks: controversy about removing benign bowel lesions. BMJ. 347(oct08 3). f5843–f5843. 11 indexed citations
17.
Silverman, Ann L., et al.. (2012). Relationship of symptom duration and fecal bacteriotherapy inClostridium difficileinfection-pooled data analysis and a systematic review. Scandinavian Journal of Gastroenterology. 48(3). 266–273. 27 indexed citations
18.
Kamiński, Michał F., Michael Bretthauer, Ann G. Zauber, et al.. (2012). The NordICC Study: Rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy. 44(7). 695–702. 119 indexed citations
19.
Holme, Øyvind, Ole Høie, Jon Matre, et al.. (2011). Magnetic endoscopic imaging versus standard colonoscopy in a routine colonoscopy setting: a randomized, controlled trial. Gastrointestinal Endoscopy. 73(6). 1215–1222. 24 indexed citations
20.
Garborg, Kjetil, et al.. (2010). Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea. Scandinavian Journal of Infectious Diseases. 42(11-12). 857–861. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alberto Fantin Breakdown of academic impact, for papers by Y F A Chung Breakdown of academic impact, for papers by Wen‐Feng Hsu Breakdown of academic impact, for papers by Paolo Bocus Breakdown of academic impact, for papers by Nansheng Cheng Breakdown of academic impact, for papers by Ganesh R. Veerappan Breakdown of academic impact, for papers by Yecheskel Schneider Breakdown of academic impact, for papers by Choong Kee Park Breakdown of academic impact, for papers by Sho Saeki Breakdown of academic impact, for papers by Sang Young Han
Rankless by CCL
2026